دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0012-3692(22)03574-7
Volume 162, Issue 4, October 2022, Pages A13-A14, A16, A18, A20, A23-A24
Should We Encourage Prone Positioning in Patients With Non-Severe COVID-19?
Alessandro Protti, MDEzio Lanza, MDMilan, Italy
doi : 10.1016/j.chest.2022.06.031
Volume 162, Issue 4, October 2022, Pages 731-733
Beyond What Meets the Eye: Artificial Intelligence in the Diagnosis of Idiopathic Pulmonary Fibrosis
Sirus J. Jesudasen, MDSydney B. Montesi, MDBoston, MA
doi : 10.1016/j.chest.2022.04.152
Volume 162, Issue 4, October 2022, Pages 734-735
Chronic Refractory Cough: A Disorder of the Brain and the Respiratory System
Peter S. P. Cho, PhDRichard D. Turner, PhDLondon, England
doi : 10.1016/j.chest.2022.06.005
Volume 162, Issue 4, October 2022, Pages 736-737
Maximum Respiratory Pressure Assessment: Standardization Is Required
Wolfram Windisch, MD, PhDCologne, GermanyCarl-Peter Criée, MD, PhDGöttingen-Weende, Germany
doi : 10.1016/j.chest.2022.05.033
Volume 162, Issue 4, October 2022, Pages 738-739
Toward Elucidating the Mechanism of Action of High-Flow Nasal Cannula Support in Children
Alexandre T. Rotta, MDKyle J. Rehder, MD, CPPS, FCCPDurham, NC
doi : 10.1016/j.chest.2022.04.010
Volume 162, Issue 4, October 2022, Pages 740-741
Veterans’ Health Administration: A Road to Health Equity in Lung Cancer Care?
Patrick Nana-Sinkam, MDRichmond, VA
doi : 10.1016/j.chest.2022.06.002
Volume 162, Issue 4, October 2022, Pages 742-743
Toward Precision Epidemiology in Bronchiolitis
Heidi Makrinioti, PhDLondon, UKCarlos A. Camargo Jr, DrPHBoston, MATuomas Jartti, PhDTurku, FinlandKohei Hasegawa, PhDBoston, MA
doi : 10.1016/j.chest.2022.06.003
Volume 162, Issue 4, October 2022, Pages 744-746
Management of Life-Threatening Asthma: Severe Asthma Series
Orlando Garner, MD; James Scott Ramey, MD; and Nicola A. Hanania, MD, FCCP
doi : 10.1016/j.chest.2022.02.029
Volume 162, Issue 4, October 2022, Pages 747-756
Development and Internal Validation of a Prognostic Model of the Probability of Death or Lung Transplantation Within 2 Years for Patients With Cystic Fibrosis and FEV1 ≤ 50% Predicted
Kathleen J. Ramos, MD; Travis Hee Wai, PhD; Anne L. Stephenson, MD, PhD; Jenna Sykes, MMath;Sanja Stanojevic, PhD; Patricia J. Rodriguez, PhD; Aasthaa Bansal, PhD; Nicole Mayer-Hamblett, PhD;Christopher H. Goss, MD; and Siddhartha G. Kapnadak, MD
doi : 10.1016/j.chest.2022.05.021
Volume 162, Issue 4, October 2022, Pages 757-767
Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
Rosario Menéndez, MD, PhD; Raúl Méndez, MD, PhD; Paula González-Jiménez, MD; Rafael Zalacain, MD, PhD;Luis A. Ruiz, MD; Leyre Serrano, MD; Pedro P. España, MD, PhD; Ane Uranga, MD, PhD; Catia Cillóniz, PhD;Luis Pérez-de-Llano, MD, PhD; Rafael Golpe, MD, PhD; and Antoni Torres, MD, PhD
doi : 10.1016/j.chest.2022.05.013
Volume 162, Issue 4, October 2022, Pages 768-781
Smartphone-Guided Self-prone Positioning vs Usual Care in Nonintubated Hospital Ward Patients With COVID-19: A Pragmatic Randomized Clinical Trial
Garrett Rampon, MD; Shijing Jia, MD; Ritwick Agrawal, MD; Nicholas Arnold, MD; Alejandro MartÃn-Quirá½¹s, MD, PhD;Ernest A. Fischer, MD; James Malatack, MD; Nikhil Jagan, MD; Amen Sergew, MD; Amy Hajari Case, MD;Kristin Miller, MD; Maged Tanios, MD; Gheorghe Doros, PhD; Craig S. Ross, PhD; Michael A. Garcia, MD;Kari R. Gillmeyer, MD; Nicholas G. Grifths, MPH; Badr Jandali, MD; Katherine L. Modzelewski, MD;Justin M. Rucci, MD; Steven Q. Simpson, MD; Allan J. Walkey, MD; and Nicholas A. Bosch, MD
doi : 10.1016/j.chest.2022.05.009
Volume 162, Issue 4, October 2022, Pages 782-791
Military Service and COPD Risk
Laura Trupin, MPHGabriela Schmajuk, MDSan Francisco, CADavid Ying, MDWalnut Creek, CAEdward Yelin, PhDPaul D. Blanc, MDSan Francisco, CA
doi : 10.1016/j.chest.2022.04.016
Volume 162, Issue 4, October 2022, Pages 792-795
Comparison of Heart Rate After Phenylephrine vs Norepinephrine Initiation in Patients With Septic Shock and Atrial Fibrillation
Anica C. Law, MD; Nicholas A. Bosch, MD; Daniel Peterson, MS; and Allan J. Walkey, MD
doi : 10.1016/j.chest.2022.04.147
Volume 162, Issue 4, October 2022, Pages 796-803
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia
Ari Moskowitz, MD; Matthew S. Shotwell, PhD; Kevin W. Gibbs, MD; Michelle Harkins, MD; Yves Rosenberg, MD; James Troendle, PhD; Lisa H. Merck, MD; D. Clark Files, MD; Marjolein de Wit, MD; Kristin Hudock, MD; B. Taylor Thompson, MD; Michelle N. Gong, MD; Adit A. Ginde, MD; David J. Douin, MD; Samuel M. Brown, MD; Eileen Rubin, JD; Meghan Morrison Joly, PhD; Li Wang, MS; Christopher J. Lindsell, PhD; Gordon R. Bernard, MD; Matthew W. Semler, MD; Sean P. Collins, MD; and Wesley H. Self, MD; for the Fourth Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-4) Host Tissue Investigators
doi : 10.1016/j.chest.2022.04.145
Volume 162, Issue 4, October 2022, Pages 804-814
Predicting Usual Interstitial Pneumonia Histopathology From Chest CT Imaging With Deep Learning
Alex Bratt, MD; James M. Williams, MD; Grace Liu, MD; Ananya Panda, MD; Parth P. Patel, BS; Lara Walkoff, MD; Anne-Marie G. Sykes, MD; Yasmeen K. Tandon, MD; Christopher J. Francois, MD; Daniel J. Blezek, PhD; Nicholas B. Larson, PhD; Bradley J. Erickson, MD, PhD; Eunhee S. Yi, MD; Teng Moua, MD; and Chi Wan Koo, MD
doi : 10.1016/j.chest.2022.03.044
Volume 162, Issue 4, October 2022, Pages 815-823
MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis
Sahajal Dhooria, MD, DM Amanjit Bal, MD Inderpaul Singh Sehgal, MD, DM Kuruswamy Thurai Prasad, MD, DM Dharambir Kashyap, MSc Riya Sharma, MSc Valliappan Muthu, MD, DM Ritesh Agarwal, MD, DM Ashutosh Nath Aggarwal, MD, DM
doi : 10.1016/j.chest.2022.04.001
10.1016/j.chest.2022.04.001
Reproducibility of Maximum Respiratory Pressure Assessment: A Systematic Review and Meta-analysis
Travis Cruickshank, PhD; Marcelo Flores-Opazo, PhD; Marcelo Tuesta, PhD; and �lvaro Reyes, PhD
doi : 10.1016/j.chest.2022.04.144
Volume 162, Issue 4, October 2022, Pages 828-850
Structural and Functional Correlates of Higher Cortical Brain Regions in Chronic Refractory Cough
Eun Namgung, PhD; Woo-Jung Song, MD, PhD; Yong-Hwan Kim, PhD; Jin An, MD, PhD; You Sook Cho, MD, PhD; and Dong-Wha Kang, MD, PhD
doi : 10.1016/j.chest.2022.04.141
Volume 162, Issue 4, October 2022, Pages 851-860
High-Flow Nasal Cannula Reduces Effort of Breathing But Not Consistently via Positive End-Expiratory Pressure
Robert D. Guglielmo, MD; Justin C. Hotz, RRT; Patrick A. Ross, MD; Timothy W. Deakers, MD, PhD; Jennifer E. L. Diep, MD; Christopher J. L. Newth, MD; and Robinder G. Khemani, MD
doi : 10.1016/j.chest.2022.03.008
Volume 162, Issue 4, October 2022, Pages 861-871
“The report of my death…�: Exaggerated Predictions on the Demise of the Stethoscope
Richard A. Reinhart, MD
doi : 10.1016/j.chest.2022.05.016
Volume 162, Issue 4, October 2022, Pages 872-877
Ethical Considerations Regarding the Use of Race in Pulmonary Function Testing
J. Henry Brems, MD Kadija Ferryman, PhD Meredith C. McCormack, MD Jeremy Sugarman, MD Baltimore, MD
doi : 10.1016/j.chest.2022.05.006
Volume 162, Issue 4, October 2022, Pages 878-881
How to Run a Code
Michelle Izmaylov, MD
doi : 10.1016/j.chest.2022.05.040
Volume 162, Issue 4, October 2022, Pages 882-883
Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study
Romil R. Parikh, MBBS, MPH; Faye L. Norby, PhD; Wendy Wang, MPH; Thenappan Thenappan, MD; Kurt W. Prins, MD, PhD; Jeremy R. Van’t Hof, MD; Pamela L. Lutsey, PhD; Scott D. Solomon, MD; Amil M. Shah, MD; and Lin Yee Chen, MD
doi : 10.1016/j.chest.2022.05.004
Volume 162, Issue 4, October 2022, Pages 884-893
Endovascular Treatment of Central Pulmonary Arterial Pseudoaneurysms in the Context of Silicosis Combined With Pulmonary TB
Xu Ma, MD Dong Yu, MD Bing Jie, MD Ling-Ling Li, MD Shanghai, China Wan Zhong, MD Ganzhou, China Ji-An Li, MD Xian, China Sen Jiang, MD
doi : 10.1016/j.chest.2022.04.138
Volume 162, Issue 4, October 2022, Pages 894-898
A Trial of Intranasal Corticosteroids to Treat Childhood OSA Syndrome
Ignacio E. Tapia, MD; Justine Shults, PhD; Christopher M. Cielo, DO; Andrea B. Kelly, MD; Lisa M. Elden, MD; Jonathan M. Spergel, MD; Ruth M. Bradford, CCRC; Mary Anne Cornaglia, CCRC; Laura M. Sterni, MD; and Jerilynn Radcliffe, PhD
doi : 10.1016/j.chest.2022.06.026
Volume 162, Issue 4, October 2022, Pages 899-919
Racial Disparities in the Surgical Treatment of Clinical Stage I Non-Small Cell Lung Cancer Among Veterans
Brendan T. Heiden, MD; Daniel B. Eaton Jr, MPH; Su-Hsin Chang, PhD, SM; Yan Yan, MD, PhD; Ana A. Baumann, PhD; Martin W. Schoen, MD; Mayank R. Patel, MD; Daniel Kreisel, MD, PhD; Ruben G. Nava, MD; Bryan F. Meyers, MD; Benjamin D. Kozower, MD; and Varun Puri, MD
doi : 10.1016/j.chest.2022.03.045
Volume 162, Issue 4, October 2022, Pages 920-929
Decision Support Tools for Low-Dose CT Lung Cancer Screening: A Scoping Review of Information Content, Format, and Presentation Methods
Mbasan Jallow, MSc; Stefanie Bonfield, MSc; Clara Kurtidu, MSc; David R. Baldwin, PhD; Georgia Black, PhD; Kate E. Brain, PhD; Michael Donnelly, PhD; Samuel M. Janes, PhD; Grace McCutchan, PhD; Kathryn A. Robb, PhD; Mamta Ruparel, PhD; Sandra Van Os, PhD; and Samantha L. Quaife, PhD
doi : 10.1016/j.chest.2021.12.638
Volume 162, Issue 4, October 2022, Pages 930-941
Alu Retroelement Copy Number and Lung Cancer Risk in the Prospective Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Wen-Yi Huang, PhD Rockville, MD H. Dean Hosgood, PhD Bronx, NY Wei Jie Seow, ScD Singapore Bryan A. Bassig, PhD Mohammad L. Rahman, MD, ScD Rockville, MD Richard B. Hayes, DDS, PhD New York, NY Nathaniel Rothman, MD Qing Lan, MD, PhD Jason Y. Y. Wong, ScD Rockville, MD Richard Cawthon, PhD Salt Lake City, UT Wei Hu, PhD Rockville, MD Somayina Ezennia, MPH St. Louis, MO Shahinaz M. Gadalla, MD, PhD Charles Breeze, PhD Batel Blechter, PhD Neal D. Freedman, PhD
doi : 10.1016/j.chest.2022.05.010
Volume 162, Issue 4, October 2022, Pages 942-945
An Unusual Case of Postpartum Empyema
Kathleen Henderson, MBChB; Rocco Bilancia, MD; Brian Choo-Kang, PhD; and John Maclay, MD
doi : 10.1016/j.chest.2022.05.019
Volume 162, Issue 4, October 2022, Pages e157-e159
Uncommon Cause of Hemoptysis in a 15-Year-Old Boy
Cristina de Manuel Gómez, MD; Sonia Milkova Ivanova; Teresa del Rosal, PhD; Carmen Cámara, MD; César Oterino Serrano, MD; MarÃa Elena Pérez Arenas; Ana Cecilia Morales Palacios; and Carlos A. de la Torre Ramos, MD
doi : 10.1016/j.chest.2022.05.031
Volume 162, Issue 4, October 2022, Pages e161-e164
A 73-Year-Old Man With Refractory Hemoptysis
Hiroshi Kobe, MD; Masashi Momose, MD; Yui Miyazaki, MD; Chika Nishihara, MD; Tomohiro Yoshida, MD; and Tadashi Ishida, MD, PhD
doi : 10.1016/j.chest.2022.04.148
Volume 162, Issue 4, October 2022, Pages e165-e168
Acute Dyspnea After Lung Transplantation: A Twisted Tale
Subha Ghosh, MD; Harpreet Singh Grewal, MD; Douglas Johnston, MD; and Atul C. Mehta, MD
doi : 10.1016/j.chest.2022.05.029
Volume 162, Issue 4, October 2022, Pages e169-e172
A 44-Year-Old Woman with Dyspnea and Hemoptysis in the Setting of Remote Bariatric Surgery
Samantha Chao, MD; Victoria Hoch, MD; Timothy Gilbert, BS; Sarah Nelson, MD; Kyle Sheetz, MD; Amir Ghaferi, MD; Elliot Wakeam, MD; and Ivan Co, MD
doi : 10.1016/j.chest.2022.05.015
Volume 162, Issue 4, October 2022, Pages e173-e176
A 62-Year-Old Immunocompromised Man With Halo Sign on Chest Imaging
Shireen R. Chacko, MD; Atul Matta, MD; Rekha Bhat, MD; Corrado Minimo, MD; Sadia Benzaquen, MD; and Ena Gupta, MD
doi : 10.1016/j.chest.2022.04.156
Volume 162, Issue 4, October 2022, Pages e177-e181
A Mediastinal Mass in a Middle-Aged Woman From a Rare Cause
Rimlee Dutta, MD; Aruna Nambirajan, MD; Sunil Kumar, MCh; Ashu Bhalla, MD; Rahul Tyagi, MD; Mehar Chand Sharma, MD; Sameer Rastogi, DM; Anant Mohan, MD; and Deepali Jain, MD, FIAC
doi : 10.1016/j.chest.2022.04.003
Volume 162, Issue 4, October 2022, Pages e183-e190
Encephalopathy and Hypoxia After Dislodgement of a Hemodialysis Catheter
Sahil Kumar Virdi, MD; and Ariel L. Shiloh, MD, FCCP
doi : 10.1016/j.chest.2021.09.044
Volume 162, Issue 4, October 2022, Pages e191-e193
A Case of Sonographic Blackout Lung
Sivaraja Subramaniam, MD; Sritharbabu Karuppasamy, DTCD; Shobana Ramu, MD; and Vimal Raj, MD
doi : 10.1016/j.chest.2021.10.051
Volume 162, Issue 4, October 2022, Pages e195-e199
All Pus Are Not Infective…
AJ Mahendran, DM Nitesh Gupta, DM
doi : 10.1016/j.chest.2022.06.041
Volume 162, Issue 4, October 2022, Page e201
Response
Kevin E. Shayani, MD Brian Birnbaum, DO Stephen Machnicki, MD Sabina Hajiyeva, MD Richard Lazzaro, MD Bushra Mina, MD
doi : 10.1016/j.chest.2022.06.040
Volume 162, Issue 4, October 2022, Page e202
Time to Consider Treatment Initiation for Patients With Nontuberculous Mycobacterial Lung Disease
Sheng-Wei Pan, MD, PhD Chin-Chung Shu, MD, PhD
doi : 10.1016/j.chest.2022.06.027
Volume 162, Issue 4, October 2022, Pages e203-e204
The Implications of Using BMI Alone in Outcomes Research
Natasha Topoluk, MD, PhD Jayshil J. Patel, MD
doi : 10.1016/j.chest.2022.06.043
Volume 162, Issue 4, October 2022, Page e204
Response
Alessia Comes, MD Rome, Italy Christopher J. Ryerson, MD
doi : 10.1016/j.chest.2022.06.044
Volume 162, Issue 4, October 2022, Pages e204-e205
Cardiac Surgery for Atrial Septal Defect Repair: Normalization of Hyperpolarized Xenon-129 MRI RBC-to-Barrier Ratio
Alexander M. Matheson, BSc Robin S. P. Cunningham Grace Parraga, PhD Michael W. A. Chu, MD Sarah Blissett, MD
doi : 10.1016/j.chest.2022.05.012
Volume 162, Issue 4, October 2022, Pages e205-e206
